Cargando…
Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
Anthracyclines are among the most powerful drugs for the treatment of oncologic diseases both in childhood and in adulthood. Nevertheless, their major antineoplastic efficacy can be seriously impaired by collateral toxic cardiac effects causing cardiomyopathy with chronic heart failure that is refra...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784784/ https://www.ncbi.nlm.nih.gov/pubmed/19930562 http://dx.doi.org/10.1186/1824-7288-35-37 |